These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15217252)

  • 21. Linking gene expression data with patient survival times using partial least squares.
    Park PJ; Tian L; Kohane IS
    Bioinformatics; 2002; 18 Suppl 1():S120-7. PubMed ID: 12169539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas.
    Muris JJ; Ylstra B; Cillessen SA; Ossenkoppele GJ; Kluin-Nelemans JC; Eijk PP; Nota B; Tijssen M; de Boer WP; van de Wiel M; van den Ijssel PR; Jansen P; de Bruin PC; van Krieken JH; Meijer GA; Meijer CJ; Oudejans JJ
    Br J Haematol; 2007 Jan; 136(1):38-47. PubMed ID: 17062006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and validation of a two-gene expression index for subtype classification and prognosis in Diffuse Large B-Cell Lymphoma.
    Xu Q; Tan C; Ni S; Wang Q; Wu F; Liu F; Ye X; Meng X; Sheng W; Du X
    Sci Rep; 2015 May; 5():10006. PubMed ID: 25940947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
    Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
    Oncotarget; 2017 May; 8(20):33487-33500. PubMed ID: 28380441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of survival prediction models based on microarray data.
    Schumacher M; Binder H; Gerds T
    Bioinformatics; 2007 Jul; 23(14):1768-74. PubMed ID: 17485430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis.
    Tome ME; Johnson DB; Rimsza LM; Roberts RA; Grogan TM; Miller TP; Oberley LW; Briehl MM
    Blood; 2005 Nov; 106(10):3594-601. PubMed ID: 16081686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
    Hummel M; Bentink S; Berger H; Klapper W; Wessendorf S; Barth TF; Bernd HW; Cogliatti SB; Dierlamm J; Feller AC; Hansmann ML; Haralambieva E; Harder L; Hasenclever D; Kühn M; Lenze D; Lichter P; Martin-Subero JI; Möller P; Müller-Hermelink HK; Ott G; Parwaresch RM; Pott C; Rosenwald A; Rosolowski M; Schwaenen C; Stürzenhofecker B; Szczepanowski M; Trautmann H; Wacker HH; Spang R; Loeffler M; Trümper L; Stein H; Siebert R;
    N Engl J Med; 2006 Jun; 354(23):2419-30. PubMed ID: 16760442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging prognostic factors in diffuse large B cell lymphoma.
    Gascoyne RD
    Curr Opin Oncol; 2004 Sep; 16(5):436-41. PubMed ID: 15314511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Data pattern analysis for the individualised pretherapeutic identification of high-risk diffuse large B-cell lymphoma (DLBCL) patients by cytomics.
    Valet GK; Hoeffkes HG
    Cytometry A; 2004 Jun; 59(2):232-6. PubMed ID: 15170602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma.
    Andreadis C; Gimotty PA; Wahl P; Hammond R; Houldsworth J; Schuster SJ; Rebbeck TR
    Blood; 2007 Apr; 109(8):3409-16. PubMed ID: 17179223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA microarrays in lymphoid malignancies.
    Rosenwald A
    Oncology (Williston Park); 2003 Dec; 17(12):1743-8; discussion 1750, 1755, 1758-9 passim. PubMed ID: 14723013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffuse large B-cell lymphoma: insights gained from gene expression profiling.
    Lossos IS; Levy R
    Int J Hematol; 2003 May; 77(4):321-9. PubMed ID: 12774918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression profiling in diffuse large B-cell lymphoma.
    Morgensztern D; Martin MG; Lossos IS
    Leuk Lymphoma; 2007 Apr; 48(4):669-82. PubMed ID: 17454624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffuse large B cell lymphoma: from gene expression profiling to prediction of outcome.
    Lossos IS
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):108-11. PubMed ID: 18162230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of biological markers of sensitivity to high-clinical-risk-adapted therapy for patients with diffuse large B-cell lymphoma.
    Saez AI; García-Cosío M; Sáez AJ; Hernández JM; Sánchez-Verde L; Alvarez D; de la Cueva P; Arranz R; Conde E; Grande C; Rodríguez J; Caballero D; Piris MA
    Leuk Lymphoma; 2009 Apr; 50(4):571-81. PubMed ID: 19373655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma.
    Rosenwald A; Wright G; Leroy K; Yu X; Gaulard P; Gascoyne RD; Chan WC; Zhao T; Haioun C; Greiner TC; Weisenburger DD; Lynch JC; Vose J; Armitage JO; Smeland EB; Kvaloy S; Holte H; Delabie J; Campo E; Montserrat E; Lopez-Guillermo A; Ott G; Muller-Hermelink HK; Connors JM; Braziel R; Grogan TM; Fisher RI; Miller TP; LeBlanc M; Chiorazzi M; Zhao H; Yang L; Powell J; Wilson WH; Jaffe ES; Simon R; Klausner RD; Staudt LM
    J Exp Med; 2003 Sep; 198(6):851-62. PubMed ID: 12975453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma.
    Wilson KS; Sehn LH; Berry B; Chhanabhai M; Fitzgerald CA; Gill KK; Klasa R; Skinnider B; Sutherland J; Connors JM; Gascoyne RD
    Leuk Lymphoma; 2007 Jun; 48(6):1102-9. PubMed ID: 17577773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphoma.
    Dunleavy K; Staudt LM; Wilson WH
    Leuk Lymphoma; 2007 Jun; 48(6):1061-3. PubMed ID: 17577765
    [No Abstract]   [Full Text] [Related]  

  • 39. Survival prediction of diffuse large-B-cell lymphoma based on both clinical and gene expression information.
    Li L
    Bioinformatics; 2006 Feb; 22(4):466-71. PubMed ID: 16339281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular profiling of lymphoma.
    Akhtar S
    N Engl J Med; 2002 Oct; 347(17):1376-7; author reply 1376-7. PubMed ID: 12397201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.